CINCINNATI (July 23, 2024) – The Christ Hospital Health Network completed the first-implant in the United States of a unique sensor designed to help heart failure patients. The procedure, performed by Sitaramesh Emani, MD, Director of Heart Failure Clinical Trials at The Christ Hospital Health Network, enables remote monitoring of patient congestion and self-management of the disease.

Vectorious Medical Technologies Ltd. developed a miniature pressure sensor that is implanted within the heart through minimally invasive transvenous catheterization. The sensor directly measures left atrial pressure (LAP), the earliest and most accurate indicator of fluid overload and congestion status. The system supports a scalable, physician-directed patient self-management approach, allowing heart failure patients to take an active role in the management of their disease. By using the V-LAP system, patients can better control their disease and adjust diuretics and fluid volume accordingly.

“The successful first U.S. V-LAP implantation represents a pivotal moment in heart failure management,” said Emani. “By integrating real-time left atrial pressure monitoring into patient care, we are on the cusp of a transformative shift towards more proactive, personalized treatment strategies. This innovative approach aims to improve patient outcomes through a reduction in hospitalizations and enhancement of overall quality of life for heart failure patients. Data collected from this trial will be game-changing for care in the future.”

“We look forward to expanding our clinical activities in the U.S. and work closely with physicians, nurses, FDA and our partners towards a pivotal trial,” said Eyal Orion, MD, co-founder and CEO of Vectorious. “Recent data published in JAMA Cardiology suggests recent plateaus or reversals after long-standing declines in cardiovascular mortality, particularly for heart failure related mortality in the U.S. between 1999 and 2021. I strongly believe that the technology and treatment paradigm we develop have the potential to reverse this concerning trend, and our team is fully committed to this mission.”

The Christ Hospital Health Network consists of an acute care hospital located in Mt. Auburn, a remote hospital location in Liberty Township, five ambulatory outpatient centers and dozens of medical offices throughout the region. For more than 130 years, The Christ Hospital has provided compassionate care to those it serves. Made up for more than 1,300 physicians and more than 6,500 team members, our mission is to improve the health of our community by providing exceptional outcomes in an affordable way. The Network was recognized by U.S. News & World Report as the #1 hospital in the Cincinnati Region and named to Newsweek’s World’s Best Hospitals list in 2024. It is also a Press Ganey Guardian of Excellence Award recipient, which recognizes top-performing healthcare organizations that achieve the 95th percentile or above of performance in patient experience.

Vectorious is a Tel Aviv-based, privately held company, founded in 2011. The company’s V-LAP System enables heart failure patients to better control their disease by remotely monitoring the heart’s Left Atrial Pressure (LAP) and detecting fluid accumulation in the earliest stages of the disease, prior to physiological symptoms. A patient app further empowers the patient to self-titrate medication in real- time based on data extracted from the heart. For more information, please visit the company website.